To test whether tumor control upon c-Myb upregulation was mediated by the adaptive immune system, we injected MC38T/O cells subcutaneously in severely immune-deficient RAG2γc-deficient mice, which lack innate lymphoid, T, B, and NK cells. The gene discussed is MYB; the disease is neoplasm.